A retrospective study found that combining a thymoma with a three-millimeter rim of surrounding tissue on CT scans improved ...

A new commentary on efgartigimod in generalized myasthenia gravis warns that post-operative myasthenic crisis is too often ...

Looking beyond near-term headwinds paints a fairly bright picture of Johnson & Johnson’s outlook.

I am currently in the middle of moving out to live on my own.I'm sorting through my belongings while working and keeping an ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid Oct 2 (Reuters) - Today we highlight a potentially unexpected ...

INTerpath-001 data to be presented in Presidential Symposium, featuring the first Phase 3 results for investigational intismeran autogene plus KEYTRUDA ® (pembrolizumab), demonstrating improvements in ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Often considered an “expendable” organ in adulthood, the thymus is a small fatty gland in the lymphatic system, located ...

A stock sharply lower in recent months For AstraZeneca alone, the molecule generated revenue of $1.8bn in 2025, giving it blockbuster status (blockbuster). Experts at the European Medicines Agency ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® ...

Motorists have been informed "it's easier than ever" following a DVLA announcement affecting motorists with any of 127 health conditions. While the majority of people can continue driving provided ...

Leonard Dragone, MD, PhD, Disease Area Leader at Johnson & Johnson, discusses how nipocalimab is being incorporated into generalized MG care, what long-term data show, and where J&J sees the therapy’s ...